These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 27235354

  • 1. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
    Küçükerden M, Huda R, Tüzün E, Yılmaz A, Skriapa L, Trakas N, Strait RT, Finkelman FD, Kabadayı S, Zisimopoulou P, Tzartos S, Christadoss P.
    J Neuroimmunol; 2016 Jun 15; 295-296():84-92. PubMed ID: 27235354
    [Abstract] [Full Text] [Related]

  • 2. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C, Çavuş F, Yılmaz V, Tüzün E.
    Immunol Invest; 2017 Jul 15; 46(5):490-499. PubMed ID: 28375749
    [Abstract] [Full Text] [Related]

  • 3. Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice.
    Ulusoy C, Kim E, Tüzün E, Huda R, Yılmaz V, Poulas K, Trakas N, Skriapa L, Niarchos A, Strait RT, Finkelman FD, Turan S, Zisimopoulou P, Tzartos S, Saruhan-Direskeneli G, Christadoss P.
    Clin Immunol; 2014 Apr 15; 151(2):155-63. PubMed ID: 24589747
    [Abstract] [Full Text] [Related]

  • 4. IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice.
    Huda R, Strait RT, Tüzün E, Finkelman FD, Christadoss P.
    J Neuroimmunol; 2015 Apr 15; 281():68-72. PubMed ID: 25867470
    [Abstract] [Full Text] [Related]

  • 5. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X, Tuzun E, Saini SS, Wang J, Li J, Aguilera-Aguirre L, Huda R, Christadoss P.
    Immunol Lett; 2015 Dec 15; 168(2):306-12. PubMed ID: 26493475
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic evidence for the involvement of Fcgamma receptor III in experimental autoimmune myasthenia gravis pathogenesis.
    Tüzün E, Saini SS, Yang H, Alagappan D, Higgs S, Christadoss P.
    J Neuroimmunol; 2006 May 15; 174(1-2):157-67. PubMed ID: 16527362
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis.
    Allman W, Saini SS, Tuzun E, Christadoss P.
    Cell Immunol; 2011 May 15; 271(2):292-8. PubMed ID: 21861992
    [Abstract] [Full Text] [Related]

  • 10. Antibodies against muscle-specific kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis.
    Mori S, Kubo S, Akiyoshi T, Yamada S, Miyazaki T, Hotta H, Desaki J, Kishi M, Konishi T, Nishino Y, Miyazawa A, Maruyama N, Shigemoto K.
    Am J Pathol; 2012 Feb 15; 180(2):798-810. PubMed ID: 22142810
    [Abstract] [Full Text] [Related]

  • 11. Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis.
    Li Z, Li M, Wood K, Hettwer S, Muley SA, Shi FD, Liu Q, Ladha SS.
    Muscle Nerve; 2018 May 15; 57(5):814-820. PubMed ID: 29193204
    [Abstract] [Full Text] [Related]

  • 12. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis.
    Yilmaz V, Ulusoy C, Hajtovic S, Turkoglu R, Kurtuncu M, Tzartos J, Lazaridis K, Tuzun E.
    Immunol Invest; 2021 Aug 15; 50(6):671-684. PubMed ID: 32597289
    [Abstract] [Full Text] [Related]

  • 13. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
    Wang W, Milani M, Ostlie N, Okita D, Agarwal RK, Caspi RR, Conti-Fine BM.
    J Immunol; 2007 Jun 01; 178(11):7072-80. PubMed ID: 17513756
    [Abstract] [Full Text] [Related]

  • 14. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM, Van Den Broeck J, Vrolix K, Janssen SP, Lemmens MA, Van Der Esch E, Duimel H, Frederik P, Molenaar PC, Martínez-Martínez P, De Baets MH, Losen M.
    Autoimmunity; 2010 Aug 01; 43(5-6):353-70. PubMed ID: 20380584
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis.
    Allman W, Qi H, Saini SS, Li J, Tuzun E, Christadoss P.
    J Neuroimmunol; 2012 Aug 15; 249(1-2):1-7. PubMed ID: 22626443
    [Abstract] [Full Text] [Related]

  • 17. [Experimental autoimmune model of muscle-specific kinase specific myasthenia gravis in rats].
    Chen Y, Wang HB, Wang YJ.
    Zhonghua Yi Xue Za Zhi; 2013 May 07; 93(17):1292-6. PubMed ID: 24029475
    [Abstract] [Full Text] [Related]

  • 18. Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis.
    Qi H, Li J, Allman W, Saini SS, Tüzün E, Wu X, Estes DM, Christadoss P.
    J Neuroimmunol; 2011 May 07; 234(1-2):165-7. PubMed ID: 21481948
    [Abstract] [Full Text] [Related]

  • 19. CD4+ T and B cells cooperate in the immunoregulation of Experimental Autoimmune Myasthenia Gravis.
    Milani M, Ostlie N, Wu H, Wang W, Conti-Fine BM.
    J Neuroimmunol; 2006 Oct 07; 179(1-2):152-62. PubMed ID: 16945426
    [Abstract] [Full Text] [Related]

  • 20. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S, Jacobson L, Waters P, Cossins J, Jacob S, Leite MI, Webster R, Vincent A.
    Exp Neurol; 2012 Apr 07; 234(2):506-12. PubMed ID: 22326541
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.